Sensex Today | Stock Market Highlights: Among the broader basket, small-cap shares were the worst hit, as the Nifty Smallcap100 index ended down by 3.56 per cent
The upward movement in Federal Bank's stock price came after the Hong Kong-based brokerage CLSA initiated coverage on the stock with an 'Outperform' rating.
Adding to the worries of investors, US is looking for possible tariffs on the pharmaceutical goods
In Q4, the company said its total deposits increased 11.8 per cent year-on-year (Y-o-Y) to ₹151,209 crore as compared to ₹135,202 crore
In Q4, the company said its customer franchise as of March 31, 2025, stood at 101.82 MM as compared to 83.64 MM as of March 31, 2024
The weakness in the oil prices came after US President Donald Trump imposed 'reciprocal' tariffs' on trading partners. He also announced a 10 per cent tariff on all countries
Tata Motor shares have corrected 44.52 per cent from its 52-week high of Rs 1,179.05, hit on July 30, 2024.
Crude oil prices fell below $70 per barrel over US President Donald Trump's new tariffs, raising concerns over a global trade war that could weigh on oil demand
Emkay analysts believe a possible US recession from tariffs could reduce Nifty's FY26 earnings by 3 per cent, potentially derating the index to 21,500 in the near-term.
The initial uptick in the Dee Development share price came after the company revealed that it has bagged an order worth Rs 55 crore.
The rise in the UCO Bank share price came on the back of a healthy Q4 provisional business update
In Q4, the bank's period-end deposits were ₹27,14,500 crore as of March 31, 2025, a growth of around 14.1 per cent over ₹23,79,800 crore as of March 31, 2024
A breakout above 23,350 could fuel further upside towards the 23,700-23,800 range, said analyst at Kotak Securities
Union Bank stock has been forming a 'Higher Top Higher Bottom' structure and has been a relative outperformer within the PSU Banking space in last couple of weeks, says Ruchit Jain of MOFSL.
Long build up is seen in the Bank Nifty futures, where we have seen 5 per cent(Prov) rise in open interest with it rising by 0.49 per cent, said Nandish Shah of HDFC Securities
The downturn in IT stocks can be attributed to fears around recession and as manufacturing hubs in China and Taiwan face new tariffs above 30 per cent
All 20 Nifty Pharma constituents settled in the green. Among others, Ipca Laboratories was up 4.59 per cent, Lupin was up 4.19 per cent, Cipla was up 3.28 per cent, Sun Pharma was up 3.41 per cent
The decline in chemical stocks followed the announcement of new tariffs by US President Donald Trump, who imposed a 27 per cent tariff on all imports from India
Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.
The prototype diesel engine will have an indigenous content of over 50 per cent and will be developed at a cost of ₹270 crore with 70 per cent funding from the Government of India